Diagnostic value of serum chitinase-3-like protein 1 in chronic liver disease of significant fibrosis and cirrhosis
10.3760/cma.j.issn.1007-3418.2018.05.005
- VernacularTitle: 血清壳多糖酶3样蛋白1在慢性肝病显著纤维化和肝硬化中的诊断价值
- Author:
Hong LI
1
;
Tong YAN
1
;
Zhen ZHU
2
;
Zuowei BAO
3
;
Tianmin XU
4
;
Jing XIE
1
;
Shuqin ZHENG
1
;
Manman CUI
4
;
Longgen LIU
1
Author Information
1. Hepatology Department, Changzhou Third People's Hospital, Changzhou 213001, China
2. Clinical Laboratory, Changzhou Third People's Hospital, Changzhou 213001, China
3. Ultrasound Department, Changzhou Third People's Hospital, Changzhou 213001, China
4. Infectious Disease Department, Changzhou Third People's Hospital, Changzhou 213001, China
- Publication Type:Journal Article
- Keywords:
Chronic liver disease;
Liver cirrhosis;
Chitinase-3-like protein 1
- From:
Chinese Journal of Hepatology
2018;26(5):337-341
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the correlation between the level of serum Chitinase-3-like protein 1 (CHI3L1) and the significant liver fibrosis and liver cirrhosis in patients with chronic liver disease, and to evaluate its diagnostic value.
Methods:165 patients with chronic liver disease were selected, liver histopathological examination was performed to detect serum CHI3L1 concentration. Four indexes of hepatic fibrosis (type III procollagen, collagen IV, laminin, hyaluronic acid), aspartate aminotransferase/platelet ratio index (APRI) and FIB-4 (fibrosis- 4) scores were based on the pathological findings of liver biopsy and compared the advantages and disadvantages of serum CHI3L1 with other methods for the diagnosis of hepatic fibrosis and liver cirrhosis. A multivariate regression analysis model was created, and receiver operating characteristic curve was analyzed.
Results:The level of serum CHI3L1 increased with increase of fibrosis stage and was highest in liver cirrhosis stage. In the period of S0 to 1, the levels of S2 to 3 and S4 were 62.82 (41.40 ~ 87.20), 70.94 (48.47 to 122.60) and 141.06 (78.18 ~ 197.40), and there were statistically significant differences between the groups (P < 0.001). The area under the curve for the diagnosis of significant liver fibrosis was 0.68 (0.60 to 0.77), and 0.74 (0.65 to 0.83) for cirrhosis in CHI3L1. Multivariate regression analysis showed that CHI3L1 was an independent predictor of significant fibrosis and cirrhosis. The combined diagnostic model based on CHI3L1, collagen IV and FIB-4 scores further improved the diagnostic value. The area under the curve for the diagnosis of significant fibrosis and cirrhosis was 0.79 (0.72 to 0.86) and 0.80 (0.73 to 0.87), respectively.
Conclusion:CHI3L1 has a good diagnostic value in patients with chronic liver disease with significant fibrosis and liver cirrhosis. The diagnostic model in combination with other markers like Collagen IV and FIB-4 scores could further improve the diagnostic value and is worthy of further study.
